Denna sida har översatts automatiskt och översättningens korrekthet kan inte garanteras. Vänligen se engelsk version för en källtext.

Impact of Tele-interventions During the COVID-19 Pandemic in Patients With Diabetes Mellitus

11 oktober 2020 uppdaterad av: Janine Alessi, Federal University of Rio Grande do Sul

Impact of Tele-Interventions During the COVID-19 Pandemic on Glycemic Control and Attitude Toward the Disease in Patients With Diabetes Mellitus - A Randomized Clinical Trial

INTRODUCTION In critical situations, such as the current COVID 19 pandemic, themes of fear, uncertainty and stigmatization are common and constitute barriers to appropriate medical and mental health interventions. These challenges, when faced by those who live with a chronic disease, such as diabetes mellitus (DM), can negatively influence quality of life and adherence to treatment, compromising the control of the disease.

OBJECTIVES The present study aims to investigate the effectiveness of a tele-intervention during the COVID-19 pandemic in improving glycemic control, lipid profile, blood pressure levels and parameters of medication adherence, mental well-being and sleep quality in patients with type 1 DM and type 2 DM.

METHODS A randomized clinical trial will be carried out with patients with a previous diagnosis of type 1 DM and type 2 DM, who are registered at the Hospital de Clínicas de Porto Alegre (HCPA). Inclusion criteria will be age greater than or equal to 18 years, collection of HbA1c in the HCPA laboratory in January, February or March 2020 and availability to receive weekly phone calls. Patients will be randomized, stratified by type of diabetes, in two groups: G1: participants will receive a tele-intervention by a case manager weekly to discuss topics related to diabetes management and mental well-being during the social distancing period ; G2: participants will receive the usual care. The primary outcome assessed will be the variation in HbA1c levels comparatively between groups, with or without a tele-guided strategy, after four months of social distancing (or as long as the recommendation of social distancing measures remains). Secondary outcomes will include experiencing confirmation of COVID-19 infection, variation in lipid profile, blood pressure levels and variation in parameters of emotional distress related to diabetes, eating disorders, medication adherence, symptoms minor psychiatric disorders and altered sleep patterns, which will be evaluated with specific and validated scales. According to the sample calculation, 150 patients will be included in the study (92 with type 2 DM and 58 with type 1 DM). Analysis by intention to treat will be performed separately for patients with type 1 DM and with type 2 DM.

SCHEDULE The proposed experiment will start immediately after approval of this project by the research ethics committee. The duration of the proposed intervention is 4 months (or as long as the recommendation of social distancing measures remains. This means that the study may be completed before or after that period, based on national recommendations for social distancing in Brazil), with a data analysis plan and publication of the results until September 2020.

Studieöversikt

Studietyp

Interventionell

Inskrivning (Faktisk)

149

Fas

  • Inte tillämpbar

Kontakter och platser

Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.

Studieorter

    • Rio Grande Do Sul
      • Porto Alegre, Rio Grande Do Sul, Brasilien, 90620-170
        • Hospital de Clinicas de Porto Alegre

Deltagandekriterier

Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.

Urvalskriterier

Åldrar som är berättigade till studier

18 år och äldre (Vuxen, Äldre vuxen)

Tar emot friska volontärer

Nej

Kön som är behöriga för studier

Allt

Beskrivning

Inclusion Criteria:

  • Type 1 diabetes mellitus or type 2 diabetes mellitus;
  • Age greater than or equal to 18 years;
  • HbA1c assessed in January, February or March 2020;
  • Availability to receive weekly phone calls

Exclusion Criteria:

  • Any severe cognitive limitation that prevents the necessary interaction to carry out this study (advanced dementia, deafness, dysarthria, aphasia);
  • Do not present a telephone record in an electronic medical record;

Studieplan

Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.

Hur är studien utformad?

Designdetaljer

  • Primärt syfte: Stödjande vård
  • Tilldelning: Randomiserad
  • Interventionsmodell: Parallellt uppdrag
  • Maskning: Ingen (Open Label)

Vapen och interventioner

Deltagargrupp / Arm
Intervention / Behandling
Experimentell: Tele-Intervention
Participants will receive a tele-intervention by a case manager weekly to discuss topics related to diabetes management and mental well-being during the quarantine period
Participants will receive a tele-intervention by a case manager weekly to discuss topics related to diabetes management and mental well-being during the quarantine period
Inget ingripande: Usual Care
Participants will receive the usual care

Vad mäter studien?

Primära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Variation in HbA1c levels
Tidsram: 4 months (or as long as the recommendation of social distancing measures remains)
Variation in HbA1c levels comparatively between groups after the period of social distancing measures.
4 months (or as long as the recommendation of social distancing measures remains)

Sekundära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
COVID-19 infection
Tidsram: 4 months (or as long as the recommendation of social distancing measures remains)
Confirmation of coronavirus infection by rapid test
4 months (or as long as the recommendation of social distancing measures remains)
Variation in lipid profile
Tidsram: 4 months (or as long as the recommendation of social distancing measures remains)
Comparison of the lipid profile of the last year with the lipid profile after the intervention between the groups.
4 months (or as long as the recommendation of social distancing measures remains)
Variation in blood pressure levels
Tidsram: 4 months (or as long as the recommendation of social distancing measures remains)
Comparison of the blood pressure level of the last consultation with the pressure after the intervention between the groups.
4 months (or as long as the recommendation of social distancing measures remains)
Comparison of emotional distress associated with the routine of living with diabetes after intervention between groups
Tidsram: 4 months (or as long as the recommendation of social distancing measures remains)
Evaluation of emotional distress associated with the routine of living with diabetes - B-PAID (Brazilian Problem Areas In Diabetes Scale)
4 months (or as long as the recommendation of social distancing measures remains)
Comparison of eating disorders between groups
Tidsram: 4 months (or as long as the recommendation of social distancing measures remains)
Evaluation of eating disorders - EAT - 26 SCALE (Teste de Atitudes Alimentares)
4 months (or as long as the recommendation of social distancing measures remains)
Comparison of adherence to the proposed clinical treatment between groups
Tidsram: 4 months (or as long as the recommendation of social distancing measures remains)
Evaluation of adherence to the proposed clinical treatment - SCI R (Self-Care Inventory - revised)
4 months (or as long as the recommendation of social distancing measures remains)
Comparison of minor psychiatric disorders between groups
Tidsram: 4 months (or as long as the recommendation of social distancing measures remains)
Evaluation of minor psychiatric disorders - SRQ 20 (Self Report Questionnaire)
4 months (or as long as the recommendation of social distancing measures remains)
Comparison of sleep pattern changes between groups
Tidsram: 4 months (or as long as the recommendation of social distancing measures remains)
Evaluation of sleep pattern changes - MSQ (Mini Sleep Questionnaire)
4 months (or as long as the recommendation of social distancing measures remains)

Samarbetspartners och utredare

Det är här du hittar personer och organisationer som är involverade i denna studie.

Publikationer och användbara länkar

Den som ansvarar för att lägga in information om studien tillhandahåller frivilligt dessa publikationer. Dessa kan handla om allt som har med studien att göra.

Studieavstämningsdatum

Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.

Studera stora datum

Studiestart (Faktisk)

17 april 2020

Primärt slutförande (Faktisk)

20 september 2020

Avslutad studie (Faktisk)

20 september 2020

Studieregistreringsdatum

Först inskickad

7 april 2020

Först inskickad som uppfyllde QC-kriterierna

10 april 2020

Första postat (Faktisk)

14 april 2020

Uppdateringar av studier

Senaste uppdatering publicerad (Faktisk)

14 oktober 2020

Senaste inskickade uppdateringen som uppfyllde QC-kriterierna

11 oktober 2020

Senast verifierad

1 oktober 2020

Mer information

Termer relaterade till denna studie

Plan för individuella deltagardata (IPD)

Planerar du att dela individuella deltagardata (IPD)?

JA

IPD-delning som stöder informationstyp

  • STUDY_PROTOCOL
  • SAV
  • ICF
  • ANALYTIC_CODE
  • CSR

Läkemedels- och apparatinformation, studiedokument

Studerar en amerikansk FDA-reglerad läkemedelsprodukt

Nej

Studerar en amerikansk FDA-reglerad produktprodukt

Nej

Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .

Prenumerera